A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Trivitron Healthcare acquires the USA based The Kennedy Company

Trivitron Healthcare, a global medical technology company, has acquired 100% shareholding in the USA based, The Kennedy Company, a leading manufacturer of Radiation Protection X-ray Shielding Material and Acoustic Barrier Products.

Trivitron Healthcare is committed to providing research-driven technologically advanced yet affordable healthcare products and with this acquisition, the company has further strengthened its manufacturing presence in the USA.

The Kennedy Company was founded in 1976, by Mr. David R. Kennedy, a physicist educated at University of London. While he was employed on the Saturn Rocket Project at the Space Technology Centre in Huntsville, he worked on developing innovative acoustic barriers for NASA.

The Kennedy Company’s 7 acres cutting-edge Technology Park in Scottsboro, Alabama will soon house multiple manufacturing and R&D facilities focusing on Trivitron’s core segments – Medical Imaging, IVD, ICU and Cardiology Equipment & Consumables.

Commenting on the acquisition, Dr. GSK Velu, Chairman & Managing Director, Trivitron said, “We are immensely pleased to welcome The Kennedy Company into the Trivitron Group. We intend to further strengthen the robust foundation created by Mr. David Kennedy and his team with Trivitron’s global presence, infrastructure, and robust manufacturing. With this acquisition, Trivitron will now have a manufacturing and R&D presence in India, USA, Finland, Turkey, China and Austria.”

Mr. Satyaki Banerjee, CEO – Medical Imaging, Trivitron Healthcare commented, “By augmenting the manufacturing experience of the Kennedy team with deep technical know-how and regulatory focus of Trivitron, we can offer the widest selection of Radiation Protection and Medical Imaging Products globally.”

“We are delighted to join the Trivitron Group. I am confident that this merger will benefit both of us and the greater Huntsville area provides the perfect backdrop to expand skilled manufacturing,” said Mr. David R. Kennedy, Founder, The Kennedy Company.

Post integration, the new entity would become a part of Trivitron Healthcare Americas, operating as Kennedy Vinyl for the existing X-ray Shielding and Acoustic Noise Control business and Kennedy Radiology for Radiation Protection Products manufactured in the USA.

The organization would be led by Mr. Sesh Sarathy, who spearheaded Trivitron Group’s M&A efforts in North America, as President, Sales and Business Development, and Mrs. Sarah Kennedy Precise, who’s been a part of the Kennedy team for more than two decades, as President, Operations.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy